For the Inventor, By the Inventor

Enter inventor name

Chesterfield, MO, United States of America

Balekudru Devadas

USPTO Granted Patents = 68 (Patent Applications = 3)

CIPO Patents = 2 (Patent Applications = 11)

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 7.6

ph-index = 10

Forward Citations = 899(Granted Patents)

Forward Citations (Not Self Cited) = 845(Dec 10, 2025)

Inventors with similar research interests:

Location History:

St. Louis, MO (US) (1994 - 1995)
Chestefield, MO (US) (1998)
Chesterfield, MO (US) (1992 - 2020)

Company Filing History:

39 out of 1,323

G.d. Searle & Company

Pharmacia Corporation

Confluence Life Sciences, Inc.

4. 3 out of 4,455

Pfizer Corporation

5. 2 out of 1,586

Washington University

G.d. Searle LLC

7. 1 out of 3,288

Monsanto Company

G. D. Dearle & Co.

Pharmacia Corporation (of Pfizer, Inc.)

Years Active: 1992-2020

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Bruton's Tyrosine Kinase Inhibitors

TAK1 Inhibitors

Substituted Pyridinone Compounds

Retroviral Protease Inhibitors

Integrin Receptor Antagonists

Cyclooxygenase Inhibitors

Sulfonamide Derivatives

Heterocyclic Compounds

Amino Acid Derivatives

Benzopyran Derivatives

Inflammation Treatment

Heteroaryl Compounds

68 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10815213 - Bruton's tyrosine kinase inhibitors (2020-10-27),

2. 10266513 - Bruton's tyrosine kinase inhibitors (2019-04-23),

3. 9505765 - 4-alkoxy/aralkoxy-5-substituted-pyrrolopyrimidine compounds as TAK1 inhibitors in disease treatment (2016-11-29),

4. 9365547 - Substituted pyridinone-pyridinyl compounds (2016-06-14),

5. 9365546 - Substituted pyridinone-pyridinyl compounds (2016-06-14),

6. 9359300 - Methyl/difluorophenyl-methoxy substituted pyridinone-pyridinyl compounds, methyl-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds, and methyl-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds (2016-06-07),

7. 9056110 - Substituted pyrimidinone-phenyl-pyrimidinyl compounds (2015-06-16),

8. 8563558 - Substituted pyridine urea compounds (2013-10-22),

9. 8507499 - Substituted indole/indazole-pyrimidinyl compounds (2013-08-13),

10. 7629363 - Diaryl substituted pyridinones (2009-12-08),

11. 7339078 - Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors (2008-03-04),

12. 7161033 - Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors (2007-01-09),

13. 7141594 - Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors (2006-11-28),

14. 7138411 - Substituted benzopyran derivatives for the treatment of inflammation (2006-11-21),

15. 7119098 - Heteroarylakanoic acids as intergrin receptor antagonists (2006-10-10),

Title: Inventor Balekudru Devadas

Introduction: Balekudru Devadas is a renowned inventor based in Chesterfield, Missouri. He is known for his groundbreaking innovations in various fields.

Latest Patents: Balekudru Devadas holds several patents in the areas of technology, healthcare, and sustainable energy. His most recent patents focus on improving renewable energy sources and enhancing medical devices.

Career Highlights: With a career spanning over two decades, Balekudru Devadas has worked with leading research institutions and companies to bring his inventions to life. He has a proven track record of turning innovative ideas into successful products.

Collaborations: Throughout his career, Balekudru Devadas has collaborated with top engineers, scientists, and designers to push the boundaries of technology. His partnerships have led to the development of cutting-edge solutions that have made a significant impact in the industry.

Conclusion: Balekudru Devadas continues to be a driving force in the world of innovation, with his passion for creating transformative technologies that shape the future. His dedication to excellence and creativity sets him apart as a visionary inventor.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…